Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Surgery|December 26, 2006
Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumorsAndrea Frilling, Frank Weber, Fuat Saner, et al.Langenbeck'S Archives of Surgery|June 10, 2009
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumorOliver Stoeltzing, Martin Loss, Elisabeth Huber, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2013
Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomasFlavio Forrer, Catharina Oechslin-Oberholzer, Benedetta Campana, et al.Cancer Cell International|July 29, 2026
Quantifying target antigen-dependent CAR T-cell performance against AMLSaumil Shah, Jan Mueller, Emanuel Vogel, et al.Melanoma Research|July 18, 2006
Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genesSandra Bloethner, Kari Hemminki, Ranjit K Thirumaran, et al.International Journal of Molecular Sciences|May 25, 2024
Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis-A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic PatientsMirko Sonntag, Vanessa K Elgeti, Yevhen Vainshtein, et al.Molecular Biology of the Cell|August 30, 2018
On the relation between filament density, force generation, and protrusion rate in mesenchymal cell motilitySetareh Dolati, Frieda Kage, Jan Mueller, et al.Cancer Immunity|May 16, 2003
In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteinsTadao Asai, Walter J Storkus, Jan Mueller-Berghaus, et al.Angiogenesis|July 6, 2006
In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's diseaseCaroline Schultheiss, Birgit Blechert, Florian C Gaertner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2002
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOCChristian Waldherr, Miklos Pless, Helmut R Maecke, et al.Pageof 7